Enrolled : Actualité Enrolled en direct - P1 | Bourse Reflex
Accueil > Tags > Enrolled

  • Toutes les actualités en rapport avec « Enrolled »

05/09 18:00 Enrolled - Quantum Genomics Receives FDA Clearance of IND Application for QGC001

30/03 18:00 Enrolled - 2016 annual financial results and next development steps in 2017

13/12 18:30 Enrolled - GENTICEL REPORTS FINAL RESULTS OF GTL001 PHASE 2 TRIAL IN HPV16/18-INFECTED WOMEN

23/06 17:45 Enrolled - GENTICEL REPORTS 18 MONTH INTERIM ANALYSIS OF GTL001 PHASE 2 TRIAL IN HPV16/18 INFECTED WOMEN

01/06 19:00 Enrolled - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

20/04 18:30 Enrolled - GENTICEL REPORTS ADDITIONAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

14/03 07:00 Enrolled - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

27/01 18:40 Enrolled - GENTICEL REPORTS INITIAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

05/01 18:00 Enrolled - Patient enrolment 100% completed for Phase IIa trial for high blood pressure

15/10 19:15 Enrolled - 2015 Half-year results - Update on latest developments

03/03 17:45 Enrolled - First patients recruited for Phase IIa trial of drug candidate QGC001

27/01 19:20 Enrolled - Business Update - Fourth Quarter 2014

26/01 20:15 Enrolled - Genticel to continue per protocol its Phase 2 clinical study with ProCervix after 2nd review by the DSMB

22/09 15:00 Enrolled - StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal Cord Injury Patient

25/07 12:30 Enrolled - Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis

06/06 12:35 Enrolled - Raptor Pharmaceutical Provides Update on Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

09/02 17:35 Enrolled - Steria launches RightTesting to help organisations save money, save time and drive efficiencies

24/01 12:30 Enrolled - Raptor Pharmaceutical Completes Enrollment in Pivotal Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis